Littérature scientifique sur le sujet « George M. Cohan »

George M. Cohan was one of the first dancers to juxtapose tap dancing with “all-American” tunes. After his Broadway success, Little Johnny Jones, a number of American-themed musicals, books, and films based on his life and repertoire followed. Such profound influence on American entertainment demonstrates how other social histories can slip under the cloak of one man's patriotism. Currently I am researching the relationship between tap dance and nation-ness on both the visual and aural levels. This paper illumines how tap dance choreographs individual and social histories, from the black man through the white man to the nation. Throughout its history, tap dance has frequently been subject to the problem of promoting white worth and values while at the same time denigrating black accomplishments. Cohan embodies this process of covering up black accomplishments by cloaking them in white American patriotism. On the Broadway stage, Cohan represents Irish America with buck-and-wing dancing and patriotic “rags,” but does so without blackface make-up. Cohan's removal of blackface deliberately attempts to remove any trace of blackness from material he deems valuable to the nation. By removing all hints of blackness from certain steps, and juxtaposing them with patriotic ditties, Cohan constructs a dance style that America can call its own. This paper locates where and how Cohan takes credit for steps and sounds with a complicated genealogy and connection to black America by performing them on a white proscenium stage.

Twelve book reviews in the May 2003 issue of Notes and Records : Brenda Maddox, Rosalind Franklin––the dark lady of DNA . Lisa Jardine, On a grander scale: the outstanding career of Sir Christopher Wren . Physicists of Ireland , edited by Mark McCartney and Andrew Whitaker. The Cambridge Companion to Newton , edited by I. Bernard Cohen and George E. Smith. David Boyd Haycock, William Stukeley: science, religion and archaeology in eighteenth-century England . Martyn Beardsley, Deadly winter: the life of Sir John Franklin . J. Browne, Charles Darwin: the power of place . M. Chisholm, Such silver currents: the story of William and Lucy Clifford 1845-1929 . Olivier Darrigol, Electrodynamics from Ampère to Einstein . Johanna Levelt Sengers, How fluids unmix: discoveries by the school of Van der Waals and Kamerlingh Onnes . Charles H. Townes, How the laser happened: adventures of a scientist . A. Macfarlane and G. Martin, The glass bathyscaphe: how glass changed the world .

Vegetation establishment is a suitable biological method of erosion control. Bank erosion is one form of water erosion and its adverse effects include an increase in turbidity, degradation of riverbank lands, difficulties caused by sediments depositing in the downstream. The rate of riverbank erosion can be decreased by application of biological methods in sensitive reaches identified. In this study, a 3250 m section of the Haraz River was studied to evaluate the effects of vegetation establishment on shear stress, water velocity and finally on the bank erosion. In this research, Geographical Information System (HEC-GeoRAS extension), HEC-RAS software, and topographic maps of riverbed at the scale of 1:500 were used to simulate hydraulic behaviour of the Haraz River. In order to evaluate the effect of vegetation cover on the bank erosion, roughness coefficient of Manning was determined with the Cowan method for two seasons (winter and summer) separately, due to changes in vegetation in the considered sections during different seasons of the year. The results showed that vegetation establishment on riverbanks caused changes in water velocity, water depth, power of shear stress and this all should finally be reflected in the rate of bank erosion.

(francuski) La question de l'origine du tsar bulgare Constantin Asen (1257-1277), plus souvent appel? dans l'historiographie moderne Constantin Tich (Tih), a ?t? depuis longtemps pos?e. Les sources susceptibles d'y r?pondre sont peu nombreuses et parfaitement r?pertori?es. A commencer par Constantin Asen lui-m?me qui, dans sa charte d?livr?e au monast?re Saint-Georges pr?s de Skopje, range 'saint Simeon Nemanja, a?eul de mon empire' au nombre des anciens kt?tors de cet ?tablissement. Pour ce qui est des auteurs byzantins, chez Georges Akropolyt?s, son contemporain, ce tsar est ? plusieurs reprises appel? Constantin fils de Tich ou simplement Constantin; un peu plus tard Georges Pachym?re le d?signe une premi?re fois comme Constantin Tich, puis, par la suite, r?guli?rement comme Constantin avec l'int?ressante pr?cision que celui-ci ?tait par sa naissance pour moitie (ex ?miseias) serbe; plus tard encore, Nic?phore Gr?goras, parle d'un puissant seigneur portant le pr?nom de Constantin et le 'nom' (ep?nymon) de Tich. En 1258/59, dans son inscription de kt?tor appos?e dans une ?glise ? Bojana, un certain s?bastocrator Kalojan fait ?tat, en sa qualit? de 'fils du fr?re du tsar' et de 'petit-fils du saint roi Stefan', de liens de parente avec le tsar r?gnant en Bulgarie, Constantin Asen, et le d?funt roi de Serbie, Stefan le Premier Couronne (Prvovencani). Enfin, dans l'historiographie byzantine, il ressort clairement du r?cit relatif a la crise de succession en Bulgarie en 1257 que Constantin n'?tait pas membre de la dynastie des Asen. Jusqu'a pr?sent, le lien de parente de Constantin Tich (Tih) avec le grand joupan de Serbie Stefan Nemanja (1166-1196), plus tard devenu moine et saint sous le nom de Simeon, a ?t? le plus souvent recherch?e ? travers une lign?e f?minine, soit une hypoth?tique fille de Nemanja inconnue des sources, qui aurait ?t? la m?re ce tsar. Cette solution pourrait cependant ne pas ?tre la seule piste envisageable. Pour cela il faut revenir ? la charte de Saint-Georges et au terme d''a?eul (de mon empire)' qui marquant la parente, peut s'appliquer dans des cas d'ascendance directe mais aussi indirecte. Constantin aurait donc pu tout aussi bien afficher a travers celui-ci une parente quelque peu plus ?loigne avec Nemanja, passant par un des fr?res, voire une tr?s hypoth?tique s?ur, de ce dernier. Ainsi, celui que nous appellerions aujourd'hui un 'grand-oncle', a pu ?tre d?sign? dans cette charte comme un 'a?eul (de mon empire)'. Qu'un tel lien de parente, m?me indirect, surtout avec saint Simeon (notamment au vu de l'essor de son culte), c'est-?-dire non seulement l'existence d'une ascendance et d'un droit de succession directs, ait pu ?tre un raison suffisante pour en appeler ? celle-ci est attest?e par l'exemple chronologiquement proche de l'inscription fun?raire du joupan Stefan Prvoslav, appos?e vers 1220, dans laquelle ce dernier est, entre autre, qualifie de 'neveu de saint Simeon Nemanja'. En ce sens, la pr?cision relev?e chez Pachym?re pourrait, elle aussi, sugg?rer, par sa formulation, que Constantin ?tait d'origine serbe par son p?re et non par sa m?re. Cet auteur s'en tenait assur?ment au principe selon lequel l'origine par le p?re ?tait sous-en-tendue, alors que l'origine par la m?re devait ?tre signal?e si n?cessaire. Les meilleurs exemples en sont les passages o? il rapporte, s'agissant du fils du roi de Hongrie Stefan IV, qu'il ?tait d''origine rom?e (r?mogen?s), par sa m?re' la fille de l'empereur Th?odore Ier, et, s'agissant du tsar de Bulgarie Th?odore Svetoslav, qu'il ?tait 'Bulgare par sa m?re, car son p?re Terter ?tait Coman'. Hormis ces remarques de nature g?n?rale, une m?me conclusion concernant l'origine du tsar de Bulgarie Constantin s'impose ?galement ? la lecture du r?cit de Pachym?re. Sa relation des troubles survenus en 1257 lors de la succession au tr?ne de Bulgarie montre qu'en l'absence de descendant male de la lign?e des Asen, les liens de parente et l'origine nationale des pr?tendants ont jou? un r?le cl? dans la r?solution de la question de la l?galit? du pouvoir et, plus g?n?rale, de la crise de succession. On y apprend que le premier candidat Myts?s (Mico), ?tait ? la fois gendre d'Ivan II Asen (1218-1241), ainsi que beau-fr?re de Th?odore II Lascaris (1254-1258) et Bulgare (Boylgaros ?n), et pouvait pr?tendre - ? ce double titre - ? exercer le pouvoir sur les Bulgares, mais que les puissants se sont ranges aux cotes de Constantin, qui ?tait pour moitie serbe (ek Serb?n ex ?miseias to genos echonta). De fait, ne pouvant se pr?valoir de quelque lien de parente avec les Asen et d'un droit quel qu'il soit ? la succession au tr?ne, Constantin a par la suite pris pour ?pouse Ir?ne, fille de Th?odore II Lascaris et ni?ce de Ivan II Asen, ce qui lui a conf?re le m?me droit au tr?ne des Asen qu'a son concurrent Myts?s (ep' is?n eiche to pros t?n toy Asan basileian dikaion t? Mytz?). Et c'est pr?cis?ment le fait que tout en ayant un p?re serbe, et une m?re, par cons?quent bulgare, c'est lui qui a ?t? d?sign? tsar gr?ce ? son prestige de puissant seigneur de Bulgarie, qui a amen? la remarque de Pachym?re. On peut difficilement imaginer que la situation inverse, ? savoir si Constantin avait eu un p?re bulgare et une m?re serbe, aurait pu avoir quelque incidence de nature politique sur le r?sultat de la crise de succession au tr?ne, au point de trouver ensuite un ?cho dans l'historiographie. Dans l'historiographie moderne il a depuis longtemps ?tait avanc? que Tich (Tih) devait ?tre une abr?viation de Tihomir, Tihoslav, Tihota ou Tihotica. Ceci nous am?ne ici ? supposer que le p?re de Constantin s'appelait en fait Tihomir. Il nous appara?t, en effet, en raison d'une similitude, voire identit?, de pr?nom que le fr?re a?n? de Nemanja, dont on pense que le pr?nom ?tait Tihomir et qui a ?t?, en son temps, grand joupan (1163/65-1166), pourrait ?tre un ?l?ment tout particuli?rement int?ressant s'agissant de la question de l'origine du tsar Constantin. Son activit? entre 1166 et 1168, apr?s que son fr?re Stefan Nemanja l'a destitu? du pouvoir, pourrait m?me ?tre rattach?e ? la Skopje byzantine. Par ailleurs, un document de l'archev?que de Ochrid Dimitrius Chomatianos, en date de 1220, fait mention d'un certain archonte de Skopje du nom de Jovan Tihomirov ou Jovan Tihomir (?toy ?I?annoy toy Teichomoiroy) - Tihomir est ici tr?s vraisemblablement un patronyme, puisqu'il est peut probable qu'il s'agisse de deux nom propres - qui, vers la fin du XIIe si?cle, r?gnait quasiment en ma?tre sur la ville. Il est donc permis de supposer l'existence d'un lien de parente entre ce Jovan et, d'une part l'ancien grand joupan Tihomir (fils) et, d'autre part, le tsar de Bulgarie Constantin (oncle ou p?re). Cette construction ne repose toutefois, pour l'essentiel, que sur une similitude de pr?noms. Partant de cette suppos?e parente entre le tsar Constantin et l'archonte de Skopje Jovan Tihomir certains chercheurs ont d?j? avance l'hypoth?se que Constantin est mont? sur le tr?ne bulgare en 1257 en tant que puissant seigneur de Skopje ou gouverneur de la r?gion de Skopje. On note cependant que d'autres chercheurs consid?rent que cette m?me ann?e 1257 a vu une br?ve domination du roi de Serbie Uros sur Skopje. Cette information, qui n'est en fait connue que d'apr?s une seule source tardive, ? savoir la charte du fils d'Uros, Milutin d?livr?e au monast?re de Chilandar en 1299/1300, a ainsi ?t? rapproch?e des ?v?nements mentionn?s dans l'Histoire de Georges Acropolit?s pour l'ann?e 1257, lorsque le roi de Serbie, en tant qu'allie du despote Michel II Ange, a pris Kicevo et d?vast? les environs de Prilep. Or, dans une charte de Milutin d?livr?e au monast?re skopiote - d?j? nomme - de Saint-Georges (Gorg) datant de cette m?me ann?e 1299/1300, le tsar bulgare Constantin figure avant le roi Uros au nombre des anciens kt?tors et donateurs du monast?re. Et il s'entend que les kt?tors sont ici tr?s certainement mentionnes selon l'ordre chronologique de la domination exerc?e sur Skopje. La charte de Constantin d?livr?e au m?me monast?re, dont la date n'est pas conserv?e, ne fait, elle non plus, nullement ?tat d'une charte ant?rieure de Uros. Et Il convient ici de prendre avec r?serve le suppose itin?raire - passant par Skopje et Polog pour atteindre Kicevo et Prilep - de l'exp?dition du roi de Serbie Uros en 1257, car des t?moignages attestent parfaitement l'existence d'un itin?raire alternatif, mais tout aussi important et utilise, allant de Prizren ? Tetovo en logeant les contreforts du massif de la Sara, de sorte qu'il ?tait possible d'atteindre Kicevo depuis les territoires du roi de Serbie sans passer par Skopje. Compte tenu de tout cela, il para?t permis d'accepter la supposition voulant que l'origine du tsar Constantin soit li?e ? Skopje et ? la r?gion de Skopje. Dans les travaux s'?tant int?ress?s ? l'origine du tsar Constantin Tich, la r?ponse ? cette question a ?galement ?t? rattach?e, sur la base de l'inscription de l'?glise de Bojana, ? celle concernant l'origine du s?bastocrator Kalojan. Il ne fait aucun doute que lui non plus n'?tait pas un Asen, car, si cela avait ?t? le cas, il aurait eu le droit de pr?tendre au tr?ne laiss? vacant ? la suite des meurtres de Michel Asen et de Kaliman, or les auteurs byzantins nous apprennent pr?cis?ment que le pouvoir n'avait pas d''h?ritier l?gal' en Bulgarie. Le t?moignage apport? par l'inscription de Bojana, selon laquelle Kalojan est un 'fils du fr?re du tsar' (? savoir le tsar Constantin) et 'petit-fils du saint roi de Serbie Stefan' (? savoir Stefan le Premier Couronn?), semblerait ?tre contradictoire. Cela n'est toutefois le cas que si nous perdons de vue le fait que la notion de parent? induite par 'fils du fr?re' (bratoucad), pouvait ?galement se rapporter ? des personnes appartenant ? diff?rentes g?n?rations. Nonobstant notre connaissance encore insuffisante des d?tails prosopographiques concernant le tsar Constantin Tich et le s?bastocrator Kalojan, ces deux Nemanjic, porteurs de titres particuli?rement ?lev?s, sont deus personnages int?ressants qui attestent parfaitement de la mobilit? horizontale et verticale au sein du monde byzantin, autrement du 'commenwealth byzantin', compris au sens le plus large.

- Tim Behrend, Nancy K. Florida, Javanese literature in Surakarta manuscripts; Volume 2; Manuscripts of the Mangkunagaran palace. Ithaca, New York: Cornell University Southeast Asia Program, 2000, 575 pp. - Harold Brookfield, Judith M. Heimann, The most offending soul alive; Tom Harrisson and his remarkable life. Honolulu: University of Hawai’i Press, 1998, 468 pp. - Harold Brookfield, Victor T. King, Rural development and social science research; Case studies from Borneo. Phillips, Maine: Borneo Research Council, 1999, xiii + 359 pp. [Borneo Research Council Proceedings Series 6.] - J.G. de Casparis, Roy E. Jordaan, The Sailendras in Central Javanese history; A survey of research from 1950 to 1999. Yogyakarta: Penerbitan Universitas Sanata Dharma, 1999, iv + 108 pp. - H.J.M. Claessen, Francoise Douaire-Marsaudon, Les premiers fruits; Parenté, identité sexuelle et pouvoirs en Polynésie occidentale (Tonga, Wallis et Futuna). Paris: Éditions de la Maison des Sciences de l’Homme, 1998, x + 338 pp. - Matthew Isaac Cohen, Andrew Beatty, Varieties of Javanese religion; An anthropological account. Cambridge: Cambridge University Press, 1999, xv + 272 pp. [Cambridge Studies in Social and Cultural Anthropology 111.] - Matthew Isaac Cohen, Sylvia Tiwon, Breaking the spell; Colonialism and literary renaissance in Indonesia. Leiden: Department of Languages and Cultures of Southeast Asia and Oceania, University of Leiden, 1999, vi + 235 pp. [Semaian 18.] - Freek Colombijn, Victor T. King, Anthropology and development in South-East Asia; Theory and practice. Kuala Lumpur: Oxford University Press, 1999, xx + 308 pp. - Bernhard Dahm, Cive J. Christie, A modern history of South-East Asia; Decolonization, nationalism and seperatism. London: Tauris, 1996, x + 286 pp. - J. van Goor, Leonard Blussé, Pilgrims to the past; Private conversations with historians of European expansion. Leiden: Research School CNWS, 1996, 339 pp., Frans-Paul van der Putten, Hans Vogel (eds.) - David Henley, Robert W. Hefner, Market cultures; Society and morality in the new Asian capitalisms. Boulder, Colorado: Westview Press, 1998, viii + 328 pp. - David Henley, James F. Warren, The Sulu zone; The world capitalist economy and the historical imagination. Amsterdam: VU University Press for the Centre for Asian Studies, Amsterdam (CASA), 1998, 71 pp. [Comparative Asian Studies 20.] - Huub de Jonge, Laurence Husson, La migration maduraise vers l’Est de Java; ‘Manger le vent ou gratter la terre’? Paris: L’Harmattan/Association Archipel, 1995, 414 pp. [Cahier d’Archipel 26.] - Nico Kaptein, Mark R. Woodward, Toward a new paradigm; Recent developments in Indonesian Islamic thought. Tempe: Arizona State University, Program for Southeast Asian Studies, 1996, x + 380 pp. - Catharina van Klinken, Gunter Senft, Referring to space; Studies in Austronesian and Papuan languages. Oxford: Clarendon Press, 1997, xi + 324 pp. - W. Mahdi, J.G. de Casparis, Sanskrit loan-words in Indonesian; An annotated check-list of words from Sanskrit in Indonesian and Traditional Malay. Jakarta: Badan Penyelenggara Seri NUSA, Universitas Katolik Indonesia Atma Jaya, 1997, viii + 59 pp. [NUSA Linguistic Studies of Indonesian and Other Languages in Indonesia 41.] - Henk Maier, David Smyth, The canon in Southeast Asian literatures; Literatures of Burma, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Thailand and Vietnam. Richmond: Curzon, 2000, x + 273 pp. - Toon van Meijl, Robert J. Foster, Social reproduction and history in Melanesia; Mortuary ritual, gift exchange, and custom in the Tanga islands. Cambridge: Cambridge University Press, 1995, xxii + 288 pp. - J.A. de Moor, Douglas Kammen, A tour of duty; Changing patterns of military politics in Indonesia in the 1990’s. Ithaca, New York: Southeast Asia Program, Cornell University, 1999, 98 pp., Siddharth Chandra (eds.) - Joke van Reenen, Audrey Kahin, Rebellion to integration; West Sumatra and the Indonesian polity, 1926-1998. Amsterdam University Press, 1999, 368 pp. - Heather Sutherland, Craig J. Reynolds, Southeast Asian Studies: Reorientations. Ithaca: Southeast Asia Program, Cornell University, 1998, 70 pp. [The Frank H. Golay Memorial Lectures 2 and 3.], Ruth McVey (eds.) - Nicholas Tarling, Patrick Tuck, The French wolf and the Siamese lamb; The French threat to Siamese independence, 1858-1907. Bangkok: White Lotus, 1995, xviii + 434 pp. [Studies in Southeast Asian History 1.] - B.J. Terwiel, Andreas Sturm, Die Handels- und Agrarpolitik Thailands von 1767 bis 1932. Passau: Universität Passau, Lehrstuhl für Südostasienkunde, 1997, vii + 181 pp. [Passauer Beiträge zur Südostasienkunde 2.] - René S. Wassing, Koos van Brakel, A passion for Indonesian art; The Georg Tillmann collection at the Tropenmuseum Amsterdam. Amsterdam. Royal Tropical Institute/Tropenmuseum, 1996, 128 pp., David van Duuren, Itie van Hout (eds.) - Edwin Wieringa, J. de Bruin, Een Leidse vriendschap; De briefwisseling tussen Herman Bavinck en Christiaan Snouck Hurgronje, 1875-1921. Baarn: Ten Have, 1999, 192 pp. [Passage 11.], G. Harinck (eds.)

У статті розглянуті мовленнєві маніпуляції як інструментальне вираження персуазивності у мовленні. Маніпуляцію розглядають як особливу комунікативно-мовленнєву стратегію здійснення впливу в політичному дискурсі, яка реалізується через низку тактик. Вибір тактик зазнає впливу концептуального стилю автора політичного дискурсу. У статті проаналізовані тактики реалізації стратегії негативної презентації «інших», зокрема, тактики «Надгенералізація» та «Екземпліфікація», як маркери концептуальних стилів президентів США Дж. Буша мол. та Б. Обами. Доведено, що особливості мовлення носіїв різних стилів зумовлюють вищу частотність певних тактик та, відповідно, нижчу частотність інших тактик. Тактика «Екземпліфікація» – це перенесення рис, що притаманні певній етнічній (чи іншій) групі загалом на конкретну подію чи особу. Ця тактика може вважатися типовою для дискурсу Дж. Буша мол., концептуальний стиль якого є аналітичним, що пояснюється дедуктивністю мовлення носіїв аналітичного стилю та їх схильністю до надмірного використання ярликів. Індуктивність мовлення Б. Обами, який є носієм реляційного концептуального стилю, пояснює вищу частотність тактики «Надгенералізація» у його дискурсі. «Надгенералізація» – це узагальнення одиничної моделі, певних аспектів часткового досвіду до загальної групової схеми. ЛітератураReferences Бережанська Ю. В. Лінгвостилістичні особливості персуазивного медичногодискурсу, присвяченого проблемі евтаназії // Наукові записки Національногоуніверситету «Острозька академія». Серія «Філологічна»: зб. наук. праць. 2014. Вип.44. С. 39–41.Berezhanska, Yu. (2014). Linhvostylistychni osoblyvosti persuazyvnoho medychnohodyskursu, prysvyachenoho problemi evtanasii [Linguo-stylistic peculiarities of medicaldiscourse dedicated to the issue of eutanasia]. Naukovi Zapysky NatsionalnohoUniversytetu “Ostroz’ka Academia”, 44, 39–41. Голоднов А. В. Лингвопрагматические особенности персуазивной коммуникации (напримере современной немецкоязычной рекламы). Автореф. дис. ... канд. филол.наук: 10.02.01. СПб., 2003.Golodnov, A. V. (2003) Lingvopragmaticheskiye osbennosti persuazivnoy kommunikatsii(na primere sovremmennoy nemetsoyazychnoy reklamy) [Lingvopragmatic peculiarities ofpersuasive communication (based on the German-speaking advertisements)]. ExtendedAbstarct of Ph.D. dissertation. St. Petersburg. Дейк Т. А. ван. Дискурс и власть: Репрезентация доминирования в языке икоммуникации/ Т. А. ван Дейк ; [пер. с англ.]. М.: Книжный дом «ЛИБРОКОМ»,2013.Dijk, T. van. (2013). Diskurs i Vlast’: Reprezentatsiya Domimirovaniya v Yazyke iKommunikatsiyi [Discourse and Power: Representation of Dominance in the Languageand Communication]. Moscow: Librokom. Доценко Е. Л. Психология манипуляции: феномены, механизмы и защита. СПб.:Речь, 2004.Dotsenko, Ye. (2004). Psikhologiya manipuliatsiyi: fenomeny, mekhanizmy i zashchita[Psychology of manipulation: phenomena, mechanisms and protection]. St. Petersburg:Rech’. Засєкіна Л. В., Засєкін С. В. Психолінгвістична діагностика. Луцьк: РВВ «Вежа»,2008.Zasiekina, L., Zasiekin, S. (2008). Psycholinhvistychna Diahnostyka [PsycholinguisticDiagnostics]. Lutsk: Vezha”. Ильченко М. Л. Метакоммуникативные тактики доминирования в американскомэлекторальном дискурсе (на материале предвыборных теледебатов) // Проблемылингвистики и лингводидактики. Вып. 1. Под ред. С. А. Моисеевой, Л. Г. Петровой.Белгород: ИПЦ «ПОЛИТЕРРА», 2013. С. 88–96.Ilchenko, M. (2013). Metakommunikativnyie taktiki dominirovaniya v amerakanskomelectoralnom diskurse (na materiale predvybornykh teledebatov) [Metacommunicative tactics of domination in American electoral discourse (based on pre-election debates)].Problemy Lingvistiki i Lingvodidaktiki, 1, 88–96. Калита А. А., Тараненко Л. И. Речевая манипуляция: определение, функция,механизм реализации // Вісник Харківського національного університету іменіВ. Н. Каразіна. Серія «Романо-германська філологія. Методика викладанняіноземних мов». 2012. № 1022. Вип. 71. С. 10–19.Kalyta, A., Taranenko, L. (2012). Rechevaya manipulyatsiya: opredeleniye, funktsiya,mekhanizm realizatsii [Speech manipulation: definition, function, mechanisms ofrealisation]. Bulletin of V. Karazin National University of Kharkiv, 71(1022), 10–19. Молодыченко Е. Н. Создание образа врага как персуазивная стратегияамериканского политического дискурса: когнитивный и лингвопрагматическийанализ: на материале публичных речей политических деятелей 1960–2008 гг:Автореф. дис. … канд. филол. наук: 10.02.04. С.-Петербург, 2010.Molodychenko, Ye. (2010). Sozdaniye obraza vraga kak persuazivnaya strategiiaamerikanskogo politicheskogo diskursa: kognitivnyy i lingvopragmaticheskii analiz: namaterial publichnykh rechey politicheskikh deyateley 1960–2008 [Enemy Image Creationas Persuasive Strategy of American Political Discourse: Cognitive and Lingual-PragmaticAnalysis: Based on Public Speeches of Politicians of 1960–2008]. Extended Abstract ofPh.D. dissertation. St. Petersburg. Серажим К. С. Дискурс як соціолінгвальне явище: методологія, архітектоніка,варіативність (на матеріалах сучасної газетної публіцистики): монографія / за ред.В. Різуна)]. Київ, 2002.Serazhym, K. (2002). Dyskurs Yak Sotsiolinhvalne Yavyshche: Metodolohiya,Arkhitektonika, Variatyvnist’ (Na Materialakh Suchasnoii Hazetnoii Publitsystyky)[Discourse as Sociolingual Phenomenon: Methodology, Archirectonics, Variability (Basedon Modern Newspaper Discourse)], V. Rizun, ed. Kyiv. Чернявская В. Е. Дискурс власти и власть дискурса: проблемы речевоговоздействия: учеб. пособие. М.: Флинта; Наука, 2006.Chernyavskaya, V. (2006). Diskurs Vlasti i Vlast’ Diskursa: Problemy RechevogoVozdeystviya [Discorse of Power and Power of Discourse: Issues of Speech Influence].Moscow: Flinta; Nauka. Cohen, R. (1969). Conceptual styles, culture conflict, and nonverbal tests of intelligence.American Anthropologist, 71(5), 828–856. Sources Nation and World. Transcript of President George W. Bush’s «Mission Accomplished»Speech. Retrieved from: http://pix11.com/2013/04/30/transcript-of-president-george-wbushs-mission-accomplished-speech/#axzz2k5GVjca0 President Bush Discusses the Middle East. July 16, 2007. Retrieved from: https://2001-2009.state.gov/p/nea/rls/rm/2007/ 88506.htm President Obama’s Full Campaign Kickoff Speech. May 05, 2012. Retrieved from:http://articles.latimes.com/2012/may/05/news/la-pn-transcript-obama-campaign-kickoff20120505 Statement by the President on Ukraine. July 18, 2014. Retrieved from:http://www.whitehouse.gov/the-press-office/2014/07 /18/statement-president-ukraine State of the Union Address. January 23, 2007. Retrieved from :http://millercenter.org/president/speeches/detail/4455 State of the Union 2012: Obama Speech Transcript. January 25, 2012. Retrieved from:http://www.washingtonpost.com/politics/state-of-the-union-2012-obama-speechexcerpts/2012/01 /24/gIQA9D3QOQ_story.html War and Appeasement. Barack Obama Speech on Bush, McCain, War and Appeasementin Watertown, South Dakota. 2008. Retrieved from: http://irregulartimes.com/index.php/archives/2008/05/16/text-transcript-of-barack-obama-speech-on-bush-mccainwar-and-appeasement-in-watertown-south-dakota-on-may-16-2008/

Abstract Introduction: The phase 2 CheckMate 205 study (NCT02181738) of nivolumab (nivo) has demonstrated high objective response rates, durable efficacy, and acceptable safety profiles in patients (pts) with relapsed/refractory classical Hodgkin lymphoma (R/R cHL) after failure of autologous hematopoietic cell transplantation (auto-HCT) regardless of prior brentuximab vedotin (BV) treatment (Younes A et al. Lancet Oncol 2016; Fanale M et al. ICML 2017 [Oral 125]). Recently proposed new response criteria aim to account for atypical patterns of response with checkpoint inhibitors which may not be fully captured by conventional response criteria (Cheson BD et al. Blood 2016; Younes A et al, Ann Oncol 2017). Studies in solid tumors have shown that pts may continue to derive clinical benefits from nivo beyond disease progression as defined by conventional criteria (George S et al, JAMA Oncol 2016; Long GV et al, JAMA Oncol 2017). Here we report outcomes among pts with R/R cHL treated beyond progression (TBP) in CheckMate 205. Methods: This single-arm, multicenter study enrolled pts (age ≥18 y) with R/R cHL after failure of auto-HCT into 3 independent cohorts (A: BV naïve, B: BV after auto-HCT, C: BV before and/or after auto-HCT). Nivo 3 mg/kg IV every 2 wk was given until disease progression or unacceptable toxicity. Response was assessed by 2007 International Working Group criteria. Best overall response (BOR) was assessed per investigator. A protocol amendment in July 2014 allowed pts to be TBP (investigator-assessed) if they met prespecified criteria, including deriving clinical benefit, stable performance status, and non-rapid progression. Pts TBP were required to discontinue in the event of further progression (≥10% increase in tumor burden). Tumor burden after initial progression was assessed in a prespecified analysis. Exploratory analyses assessed overall survival (OS) and time to next therapy (TTNT) in pts TBP. Results: In total, 70/243 (29%) pts were TBP: 19 in Cohort A, 23 in B, and 28 in C. Demographics were similar to the overall study population: 57% had stage IV disease at study entry, median (range) age was 37 (18-72) y, and median number of prior therapies was 3 (2-5). BOR prior to progression was complete remission (CR) in 5 (7%) pts, partial remission (PR) in 31 (44%), stable disease (SD) in 20 (29%), and progressive disease in 13 (19%) (BOR was non-evaluable in 1 pt). Among pts TBP, the initial cause of progression was a ≥50% increase in total tumor burden in 13 (19%) pts, non-target lesion progression in 17 (24%), and new lesions in 47 (67%) (pts could have multiple findings as reasons for progression). The median time to initial progression in pts TBP was 6 mo; 11 mo in pts with initial BOR of CR and 7 mo in pts with initial PR or SD. At December 2016 database lock, median (range) doses of nivo beyond progression were 8 (1-43), and median duration of treatment beyond progression was 5 (0-19) mo. Overall, 21 (30%) pts TBP remained on treatment; the most common reason for discontinuation was further disease progression (80%). The majority of pts TBP demonstrated stable reductions in tumor burden with continued treatment. Median (95% CI) TTNT from first study dose of nivo was 17 (14, not estimable) mo (Figure). Median OS from date of initial progression was not reached in pts TBP and OS was 84% (95% CI 70, 92) at 1 y. Treatment-related adverse events (TRAEs) occurred in 46% of pts (13% grade [G] 3-4) after progression, vs 64% (9% G3-4) prior to progression. Serious TRAEs after progression were aspartate aminotransferase increase (n=1) and hypercalcemia (n=1), both G3-4. Ten deaths occurred in pts TBP; 7 were due to disease progression and none were considered related to study drug. Conclusions: In total, 29% of pts from CheckMate 205 Cohort A/B/C were TBP. New lesions were the most common reason for initial progression in pts TBP. Stable reductions in tumor burden were seen with continued treatment in pts TBP, and median TTNT and OS remained high. Proposed updates to response criteria may help to better assess the long-term efficacy of checkpoint inhibitors. These data suggest that pts considered to show stable performance status, non-rapid progression, and clinical benefits despite progression according to conventional response criteria may derive long-term benefits from continued nivo treatment. Study funding: BMS. Writing support: Simon Wigfield, Caudex, funded by BMS. Disclosures Cohen: Bioinvent: Consultancy, Membership on an entity's Board of Directors or advisory committees; Genentech: Consultancy, Membership on an entity's Board of Directors or advisory committees; Takada: Research Funding; Bristol Myers Squibb: Research Funding; Abbvie: Consultancy, Membership on an entity's Board of Directors or advisory committees; Infinity: Consultancy, Membership on an entity's Board of Directors or advisory committees; Janssen: Consultancy, Membership on an entity's Board of Directors or advisory committees; Novartis: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; LAM Therapeutics, Inc: Research Funding. Engert: Amgen: Honoraria, Research Funding; Bristol-Myers Squibb: Consultancy, Honoraria, Research Funding; Takeda: Consultancy, Honoraria, Research Funding; Affimed: Consultancy, Honoraria, Research Funding. Ansell: Merck: Research Funding; Celldex: Research Funding; Seattle Genetics: Research Funding; Bristol-Myers Squibb: Research Funding; Affimed: Research Funding. Younes: Roche: Consultancy, Honoraria, Other: Third-party medical writing assistance, under the direction of Anas Younes, was provided by Scott Malkin of Gardiner-Caldwell Communications, and was funded by F. Hoffmann-La Roche Ltd.; Bayer: Honoraria; Bristol-Myers Squibb: Honoraria; Novartis: Research Funding; Janssen: Honoraria; Merck: Honoraria; Curis: Research Funding; Sanofi: Honoraria; Takeda Millenium: Honoraria; Johnson & Johnson: Research Funding; Seattle Genetics: Honoraria; Incyte: Honoraria; Celgene: Honoraria. Trneny: Celgene: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Gilead: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Janssen: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Roche: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; Takeda: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees. Savage: Roche: Research Funding; Seattle Genetics: Consultancy, Honoraria; Bristol-Myers Squibb: Honoraria; Merck: Honoraria; Celgene: Consultancy. Ramchandren: Seattle Genetics: Consultancy; Janssen: Research Funding; Merck: Research Funding; Pharmacyclics: Research Funding. Collins: ADC Therapeutics: Research Funding; Roche: Consultancy, Honoraria, Speakers Bureau; Pfizer: Consultancy, Honoraria; Celgene: Research Funding; Celleron: Consultancy; MSD: Consultancy, Honoraria; Takeda: Consultancy, Honoraria, Speakers Bureau; Bristol-Myers Squibb: Research Funding; Amgen: Research Funding. Fanale: AMGEN: Membership on an entity's Board of Directors or advisory committees; CELGENE: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; TAKEDA: Honoraria, Research Funding; ONYX: Research Funding; SEATTLE GENETICS: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; MOLECULAR TEMPLATES: Research Funding; MERCK: Membership on an entity's Board of Directors or advisory committees, Research Funding; BMS: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding; GENENTECH: Research Funding; ADC THERAPEUTICS: Research Funding. Armand: Bristol-Myers Squibb: Consultancy, Other: research funding (institutional); Merck: Consultancy, Other: research funding (institutional); Infinity: Consultancy; Pfizer: Consultancy, Other: research funding (institutional); Affimed: Other: research funding (institutional); Otsuka: Other: research funding (institutional); Sequenta: Other: research funding (institutional); Sigma Tau: Other: research funding (institutional); Roche: Other: research funding (institutional); Tensha: Other: research funding (institutional). Zinzani: Bayer: Honoraria, Membership on an entity's Board of Directors or advisory committees; Roche: Honoraria, Membership on an entity's Board of Directors or advisory committees; Celgene: Honoraria, Membership on an entity's Board of Directors or advisory committees; Gilead: Honoraria, Membership on an entity's Board of Directors or advisory committees; Johnson & Johnson: Honoraria, Membership on an entity's Board of Directors or advisory committees; Bristol-Myers Squibb: Honoraria, Membership on an entity's Board of Directors or advisory committees; Karyopharm Therapeutics: Honoraria, Membership on an entity's Board of Directors or advisory committees; Verastem: Honoraria, Membership on an entity's Board of Directors or advisory committees; Merck: Honoraria, Membership on an entity's Board of Directors or advisory committees; Servier: Honoraria, Membership on an entity's Board of Directors or advisory committees; Takeda: Honoraria, Membership on an entity's Board of Directors or advisory committees. De Boer: Bristol-Myers Squibb: Membership on an entity's Board of Directors or advisory committees; MSD: Membership on an entity's Board of Directors or advisory committees; Merck: Membership on an entity's Board of Directors or advisory committees, Other: Non-restricted grant for research in head and neck cancer; Eisai: Membership on an entity's Board of Directors or advisory committees; Astellas: Other: member of Independent Data Monitoring Committee. Shipp: Cell Signaling: Honoraria; Bristol-Myers Squibb: Membership on an entity's Board of Directors or advisory committees, Research Funding; Bayer: Research Funding; Takeda: Other: Scientific Advisory Board; Merck: Other: Scientific Advisory Board; Gilead: Other: Scientific Advisory Board; AstraZeneca: Honoraria. Santoro: Merck: Membership on an entity's Board of Directors or advisory committees; Bristol-Myers Squibb: Membership on an entity's Board of Directors or advisory committees. Timmerman: Seattle Genetics: Consultancy; Celgene: Consultancy; Bristol-Myers Squibb: Consultancy, Honoraria, Other: Travel expenses, Research Funding; Genmab: Consultancy, Equity Ownership; Kite Pharma: Research Funding; ImmuneGene: Research Funding. Sacchi: Bristol-Myers Squibb: Employment. Sy: Bristol-Myers Squibb: Employment. Kuruvilla: BMS: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Gilead: Consultancy, Honoraria; Janssen: Consultancy; Hoffman LaRoche: Consultancy; Seattle Genetics: Consultancy, Honoraria; Amgen: Honoraria; Roche: Honoraria; Janssen: Honoraria; Lundbeck: Honoraria; Merck: Honoraria; Karyopharm: Research Funding; Roche: Research Funding; Celgene: Honoraria, Research Funding.

This dissertation examines the Americanization of immigrants as a defining theme in American musical theater. It does so through studies of productions from across the past century about Irish Americans, Chinese Americans, and Latino/a Americans, and in each case, at least one of the creators is a member of the ethnic American group depicted. I contend that these artists found the musical to be a constructive tool for voicing their experiences of the struggle of Americanization and broadening notions of American identity. The resulting narrative expands upon the substantial "golden age"-centered literature on Jewish assimilation and the American musical. Decentralizing the "golden age," I show how the genre has helped write into cultural citizenship a broad range of immigrant groups during fraught periods in which their national belonging was contested. I draw upon a wide range of disciplines - especially immigration history, ethnic studies, and American studies as well as musicology - and diverse methods, including archival research, oral history, textual and musical analysis, reception history, and historically based hermeneutics.
Music

After an initial account of Captains of the Clouds, this chapter provides a detailed description about the making of Yankee Doodle Dandy (1942).The legendary show business powerhouse George M. Cohan agreed to let Warner Bros. produce an idealized musical film of his life, but he had to be convinced to inject any type of drama into the screenplay. James Cagney had returned to the studio in 1938 with greatly increased power. With some misgivings, Cagney accepted the Cohan role in Yankee Doodle Dandy (partially for political reasons) and worked seamlessly with Curtiz to create a memorable film.First-person accounts by Joan Leslie and Rosemary DeCamp enliven the depiction of a synergistic production led by a dedicated Curtiz.Behind the scenes, the intermittent wrangling that pitted Cagney and his brother William (who was associate producer) against the screenwriter Robert Buckner, Jack Warner, and Wallis ended when Cagney gave notice that he was vacating his Warner contract after the picture was finished. Yankee Doodle Dandy was a humongous hit for the studio and Curtiz, who considered it the “pinochle” of his career.